Request a copy of the file

Enter the following information to request a copy for the following item: The value of the MDR1 reversal agent PSC-833 in addition to daunorubicin and cytarabine in the treatment of elderly patients with previously untreated acute myeloid leukemia (AML), in relation to MDR1 status at diagnosis.

Requesting the following file: 26950.pdf